GPCR News

Post: Blog2_Post

GPCR News
- Jul 1, 2022
- 1 min read

Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...

Updated: Aug 18, 2022

July 2022

"Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical space and precision-engineer therapeutics with enhanced potency and tailored signaling against an undrugged GPCR target.

#ai #drugdiscovery #gpcr"

Recent Posts

See All

Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...

August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi "San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics

Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner

Amgen to Acquire Chemocentryx for $4 Billion in Cash

August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally admin